Fair-value, exchange gains boost Cordlife's Q3 bottom line
Singapore
CORDLIFE Group reported on Monday net profit of S$18.1 million for the third quarter ended March 31, 2015, representing a surge of more than 10 times from S$1.5 million for the corresponding period a year ago.
The boost came as financial-asset and derivative gains for the period totalled S$11.3 million. Also helping were S$4.6 million in exchange differences. Revenue for the group, which has the largest market share of private cord blood banks in Singapore, Indonesia and the Philippines, rose 20.9 per cent to S$14.3 million, driven by an increase in the number of client deliveries from about 4,100 a year ago to 5,400.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Geely, Foretellix partner to jump-start self driving car development
US: Wall Street opens slightly higher on rate cut optimism
Far East Orchard net profit up 46.8% to S$6.9 million in Q1
US dollar inches up; Aussie, yen slide
Singapore architectural firm wins US$28 million deal to light up mega theme park in Saudi Arabia
Cordlife hiring more technical and laboratory staff to ‘strengthen core processes’